Salix Partners with the Colorectal Cancer Alliance on Community Screening Program Pharmaceutical Investing
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement Pharmaceutical Investing
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting Pharmaceutical Investing
Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change Pharmaceutical Investing
BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
Gilead Sciences: Breaking Down Barriers To Access in HIV and Beyond: A Perspective Pharmaceutical Investing
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business Pharmaceutical Investing
Jamieson Wellness Inc. Announces Date of First Quarter 2023 Financial Results and Conference Call Life Science Investing News
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc. Pharmaceutical Investing
